Celularity (CELUW) Profit After Tax (2019 - 2025)
Celularity (CELUW) reported Profit After Tax of -$24.4 million for Q4 2025, up 15.45% year-over-year from -$21.1 million in Q4 2024, and down 88.85% quarter-over-quarter from -$12.9 million in Q3 2025.
Celularity (CELUW) Profit After Tax (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Profit After Tax data on file, last reported at -$24.4 million in Q4 2025.
- Profit After Tax for Q4 2025 came in at -$24.4 million, up 15.45% year-over-year; the trailing twelve-month figure through Dec 2025 was -$81.5 million (down 18.45% YoY), and the FY2025 annual result was -$91.7 million, down 58.43% from the prior year.
- Profit After Tax retreated to -$24.4 million in Q4 2025 per CELUW's latest filing, from -$12.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $47.8 million in Q2 2022 and troughed at -$93.9 million in Q3 2023.
- A 5-year average of -$21.2 million and a median of -$20.9 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 704.8% in 2022, then slumped 1562.7% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$4.0 million in 2021, then jumped by 704.8% to $24.4 million in 2022, then slumped by 60.93% to $9.5 million in 2023, then slumped by 401.81% to -$28.8 million in 2024, then climbed by 15.45% to -$24.4 million in 2025.
- Business Quant data shows CELUW's Profit After Tax at -$24.4 million in Q4 2025, -$12.9 million in Q3 2025, and -$24.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -24.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.36 Mn |
| Sep 30, 2025 | -12.90 Mn |
| Jun 30, 2025 | -24.52 Mn |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -28.81 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -6.49 Mn |
| Mar 31, 2024 | -22.01 Mn |
| Dec 31, 2023 | 9.55 Mn |
| Sep 30, 2023 | -93.88 Mn |
| Jun 30, 2023 | -47.95 Mn |
| Mar 31, 2023 | -64.02 Mn |
| Dec 31, 2022 | 24.43 Mn |
| Sep 30, 2022 | -5.65 Mn |
| Jun 30, 2022 | 47.83 Mn |
| Mar 31, 2022 | -41.61 Mn |
| Dec 31, 2021 | -4.04 Mn |
| Sep 30, 2021 | 10.90 Mn |
| Jun 30, 2021 | -64.48 Mn |
| Mar 31, 2021 | -44.40 Mn |